Avantor, Inc., a leading global provider of mission-critical products and services, is headquartered in the United States. Founded in 1904, the company has established a strong presence in the life sciences and advanced technologies sectors, serving customers across various industries, including pharmaceuticals, biotechnology, and education. With a diverse portfolio that includes high-quality laboratory supplies, chemicals, and custom manufacturing solutions, Avantor distinguishes itself through its commitment to innovation and customer-centric approach. The company has achieved significant milestones, including strategic acquisitions that have expanded its operational footprint in key regions worldwide. Recognised for its market leadership, Avantor continues to drive advancements in scientific research and development, making it a trusted partner for organisations seeking reliable and efficient solutions in the ever-evolving landscape of science and technology.
How does Avantor's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Avantor's score of 37 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Avantor reported total greenhouse gas emissions of approximately 26,095,000 kg CO2e for Scope 1 and about 28,933,000 kg CO2e for Scope 2, resulting in a combined total of around 55,028,000 kg CO2e for both scopes. This reflects a slight increase in emissions compared to 2022, where Scope 1 emissions were about 25,340,000 kg CO2e and Scope 2 emissions were approximately 32,507,000 kg CO2e, leading to a total of around 57,847,000 kg CO2e. Avantor has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and Scope 2 greenhouse gas emissions by 15% by 2025, using 2019 as the baseline year. Furthermore, the company has committed to a more extensive reduction target of 50% for both Scope 1 and Scope 2 emissions by 2030, alongside a 25% reduction in Scope 3 emissions within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are designed to support global efforts to limit temperature rise to 1.5°C. Overall, Avantor's emissions reduction strategy reflects a proactive approach to sustainability within the pharmaceuticals, biotechnology, and life sciences sector, demonstrating a commitment to environmental responsibility and climate action.
Access structured emissions data, company-specific emission factors, and source documents
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Scope 1 | 27,871,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 2 | 38,194,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | - | - | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Avantor is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.